Owl Wings Glow Pink And It Could Be Sending a Secret Message
The long-eared owl, Asio otus, is a majestic raptor known for its perky horn-like ear tufts, and cryptic herringbone markings that help it meld into its arboreal habitat. But in certain light, scientists discovered, its dappled forest camouflage is betrayed by fluorescent, day-glo pink wing feathers.
Ornithologist Emily Griffith and her colleagues, from Northern Michigan University and the state's Whitefish Bird Point Observatory, examined feathers collected from the inner wings of 99 long-eared owls as the birds migrated through Michigan's Upper Peninsula in the Spring of 2020.
They wanted to catalog the various rosy shades of fluorescent pigments this population sported, to see if they could decode what it might mean to those who can see it.
Owl eyes can detect this magenta fluorescence – emitted by photosensitive pigments called porphyrins, from the Greek word for purple – even without the aid of a UV light, as can other birds with the ability to see in the ultraviolet spectrum.
The fact that it's not in the spectrum visible to our own mammal eyes suggests it may be a perfect way of signaling to its peers without being detected by its main prey – rodents and other small mammals.
The photosensitivity of porphyrins not only causes them to glow in the first place, it also makes them degrade with continual exposure to sunlight, which often means that avian fluorescence fades with feather age between molts.
We know that other kinds of pigments in bird feathers play a role in signaling age, sex, size, and overall health to potential competitors and mates. For instance, even without a blacklight the researchers could guess the sex of long-eared owls by their dark (female) or light (male) plumage, although even this system is not foolproof, with roughly one third of the owls left without an assigned sex due to their intermediate coloring.
But it's yet unknown if similar messages are written in these owls' ultraviolet undergarments.
Griffith and team found feathers from older birds had much higher concentrations of the fluorescent pigments than younger birds, and were stronger in the darker-plumed females than in the light-colored males.
Younger birds, and those with paler plumage overall, had stronger pigments if they were heavier. This, the authors note, suggests the pigments could function as an 'honest signal' of an owl's health.
"It is possible that fluorescent pigments exhibited in long-eared owls are used in sexual selection," the authors write. "The only time in which these pigments may be directly on display (besides during flight) would be during courtship behavior, during which the male performs a courtship flight to attract females."
But even if the owls were keenly attuned to the subtle differences in wing glow flaunted during male flight, it doesn't explain why females' wings should be so much brighter.
"Moreover, this trait doesn't follow a strict binary – the amount of fluorescent pigments in these owls exists on a spectrum where the amount of pigment is related to size, age, and sex all together," Griffith says.
The team suspects something else might be driving the major pigment differences: heat regulation. Fluorescent pigments in eggshells are known to help regulate heat by reflecting infrared wavelengths, and they could serve a similar function in the females' inner wing feathers, limiting heat loss while nesting.
"This alternate hypothesis would explain why females have significantly more fluorescent pigments, as males do not incubate and are more physically active as they hunt for prey items while females take the primary role in incubation," the authors write.
This research is published in The Wilson Journal of Ornithology.
Strange Bacteria That Can't Live Alone Hint at Early Steps to Complex Life
Mysterious 3-Toed Footprints in Canada Reveal New Ankylosaur Species
Origins of Earth's Water May Not Be as Complicated as We Thought
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
2 days ago
- New York Post
‘Spectacular' temple dedicated to Ancient Greek God uncovered by archaeologists: 2,700-year-old treasures found
Archaeologists have unearthed a 'spectacular' ancient temple housing hundreds of statues dedicated to the Greek God Apollo. The site, known as the Sanctuary of Apollo, is located in a remote valley in Cyprus, and the uncovered artifacts are believed to date back 2,700 years. A team of German experts initially began excavating in the area in 2021, with the finds of their four-year dig disclosed in a statement from the Cyprus Department of Antiquities. '[The sanctuary] was furnished with a lavish abundance of votive statues numbering in the hundreds, some of which were of colossal dimensions,' the statement, translated from Greek to English, read. 'In addition, evidence of other previously unknown types of votive objects was also found, such as marbled glass beads or Egyptian amulets made of faience [tin-glazed pottery].' The site, known as the Sanctuary of Apollo, is located in a remote valley in Cyprus, and the uncovered artifacts are believed to date back 2,700 years. Department of Antiquities Cyprus Three ancient statues from the Apollo sanctuary at Frangissa. Department of Antiquities Cyprus Apollo, the Greek god of archery and the son of Zeus, was a prominent deity in ancient Greek and Roman mythology. The Sanctuary of Apollo was first discovered by German archaeologist Max Ohnefalsch-Richter in 1885, and was 'considered one of the most spectacular finds of its time.' However, following his 'inadequate' excavations, Ohnefalsch-Richter reburied the site, causing its precise whereabouts to be forgotten for over a century. In 2021, the new team of German archaeologists rediscovered the long-lost temple in the remote valley of Frangrissa, near the ancient city-kingdom of Tamassos. After conducting a more extensive examination of the site, they uncovered treasures that were initially overlooked, including fragments of colossal statues, parts of which appeared to be feet. 'Apparently in 1885 [the votive statues] were not recognized as artifacts in the rush,' the new statement from the Cyprus Department of Antiquities declared. Thus, the new finds 'fundamentally expand our knowledge of this sacred place.' 'Μany statues in the Cyprus Museum and the Royal Ontario Museum at Toronto can be completed with newly found fragments and thus restored to their original appearance,' the statement continued. 'Completely new types of statues have also been documented that were previously unknown from Frangissa. The discovery of clearly larger-than-life feet, for example, means that the existence of colossal male limestone figures from archaic times can now be proven.' 'Such larger-than-life figures were previously only known here in Frangissa made from terracotta, including the famous 'Colossus of Tamassos' in the Cyprus Museum exhibition.' Meanwhile, the discovery of two inscriptions on the bases of the figures dates them to the 6th and 7th centuries BC. 'The discovery of two bases with inscriptions is spectacular,' the statement read. 'One is inscribed with several local Cypro-Syllabic characters, while the other refers in Greek letters to the Ptolemies, the Hellenistic rulers of Egypt who also controlled Cyprus at the time.'
Yahoo
3 days ago
- Yahoo
How stress shapes cancer's course
About two millennia ago, the Greek physicians Hippocrates and Galen suggested that melancholia—depression brought on by an excess of "black bile" in the body—contributed to cancer. Since then, scores of researchers have investigated the association between cancer and the mind, with some going as far as to suggest that some people have a cancer-prone or "Type C" personality. Most researchers now reject the idea of a cancer-prone personality. But they still haven't settled what influence stress and other psychological factors can have on the onset and progression of cancer, Knowable Magazine notes. More than a hundred epidemiological studies—some involving tens of thousands of people—have linked depression, low socioeconomic status and other sources of psychological stress to an increase in cancer risk, and to a worse prognosis for people who already have the disease. However, this literature is full of contradictions, especially in the first case. In recent decades, scientists have approached the problem from another angle: experiments in cells and animals. These have revealed important mechanisms by which stress can alter tumors, says Julienne Bower, a health psychologist at UCLA who coauthored a 2023 article on the connection between the brain and the immune system in diseases, including cancer, in the Annual Review of Clinical Psychology. Such studies are showing that "psychological factors can influence aspects of actual tumor biology," she says. On the flip side, studies in people and animals suggest that blocking the chemical signals of stress may improve cancer outcomes. Today, a growing number of researchers think that psychological factors can influence cancer's progression once someone has the disease. "I don't think anyone appreciated the magnitude by which even mild stress, if it's chronic, can have such a negative influence on cancer growth," says Elizabeth Repasky, a cancer immunologist at the Roswell Park Comprehensive Cancer Center in Buffalo, New York. New interest in the relationship between stress and cancer growth emerged in part from research into how stress affects the body's response to human immunodeficiency virus (HIV). In the 1990s and early 2000s, genomics researcher Steve Cole and his team at UCLA investigated why people infected with HIV who were under high stress tended to have worse outcomes, including larger viral loads and poorer responses to antiretroviral drugs. Cole's team discovered several routes through which stress could worsen HIV infections. In monkeys, they found, the lymph nodes of stressed animals had many more connections to sympathetic nerve cell fibers—which execute the body's fight-or-flight response—than the nodes of unstressed monkeys. Lymph nodes contain immune cells, and the nerve fibers reduced the antiviral function of these cells, which, in turn, led to an increase in the replication of a version of HIV that infects monkeys and apes. Lymph nodes, in addition to housing immune cells, also act as the body's drainage system, flushing away toxins through a network of tissues, organs and nodes called the lymphatic system. Importantly, cancer cells can hijack this system, using it to travel through the body. Erica Sloan, a postdoctoral trainee of Cole who was involved in the HIV work, wondered whether stress, via the sympathetic nervous system, might also affect lymph nodes in those with cancer. Sloan, now a cancer researcher at Monash University in Australia, went on to discover in mice that chronic stress increases the number of connections between the lymphatic system and breast tumors, making the cancer cells more likely to spread. Strikingly, treatment with a drug—a beta blocker that blunts the activity of key molecules of the sympathetic nervous system such as norepinephrine—prevented these effects. Research by other groups has shown that stress can lead to molecular changes, particularly within the immune system, that influence how cancer progresses. Some of this work suggests that, when stress leads to inflammation—a broad immune reaction typically brought on by injuries and infections—it can boost the growth of tumors. Stress can also impair the activity of immune cells that play an active role in fighting cancer. In the early 2000s, research by University of Iowa behavioral scientist Susan Lutgendorf and her colleagues found that in patients with ovarian cancer, depression and anxiety were associated with impaired tumor-fighting immune cells. In another study of people with ovarian cancer, the researchers found that poor social support was linked to higher levels of a growth factor that stimulates blood vessel growth around tumors. This growth, called angiogenesis, enables new blood vessels to supply nutrients to tumors and—like the lymphatic system—provide pathways through which cancer cells can spread to other parts of the body. Lutgendorf and her colleagues have since found that stressful situations have a similar effect on mice with ovarian cancer, enhancing tumor angiogenesis and cancer spread. Equally important, they've found that these effects can be reversed with beta blockers. Other groups have found similar effects of blocking stress signals on other types of cancer in rodents, including blood and prostate cancer. In addition, researchers have found that increasing levels of stress hormones such as norepinephrine and cortisol in mice can make previously dormant cancer cells more likely to divide and form new tumors. Studies like these are revealing that stress can trigger a cascade of biochemical changes and alter a cancer cell's environment in a way that may promote its spread. "Stress signaling and stress biology really have an impact on most—if not all—of these processes," says Jennifer Knight, a cancer psychiatrist at the Medical College of Wisconsin. If stress can make cancer worse, how can the process be stopped? Little by little, new treatments are emerging. For about half a century, clinicians have used beta blockers to treat hypertension. By scouring data from patient registries, researchers found that people with cancer who already had been taking certain kinds of beta blockers at the time of diagnosis often had better outcomes, including longer survival times, than those who were not on the medicines. Over the past few years, several clinical trials—most of which are small and early-stage—have directly tested whether beta blockers could benefit people with cancer. In one pair of studies, a research team led by neuroscientist Shamgar Ben-Eliyahu at Tel Aviv University, administered the beta blocker propranolol along with an anti-inflammatory drug to people with colorectal or breast cancer five days before surgery. The team chose this timing because earlier research had shown that while surgery is an opportunity to remove the tumor, it can also paradoxically provide the chance for the cancer to spread. So blocking any potential effects of stress on cancer spread, they reasoned, could be crucial to a patient's long-term prognosis. These trials, which involved dozens of patients, revealed that the tumor cells of those who received the drugs showed fewer molecular signs of being able to spread—a process known as metastasis—less inflammation, and an increase in some tumor-fighting immune cells. For colorectal cancer patients, there were also hints that the intervention could reduce cancer recurrence: Three years after the procedure, cancer returned in two of the 16 patients who received the drugs, compared to six of 18 patients who didn't receive those meds. Other studies have assessed the effect of using beta blockers alone, without anti-inflammatory drugs. In 2020, Sloan and her colleagues published a study including 60 breast cancer patients, half of whom were randomly assigned to receive propranolol a week before surgery, while the other half received a placebo. They, too, found that tumor cells from patients who received beta blockers had fewer biomarkers of metastasis. Stress-reducing beta blockers may also benefit other cancer treatments. In a 2020 study, Knight and her team looked at the effect of beta blockers in 25 patients with multiple myeloma who were receiving blood stem cell transplants. Patients who took beta blockers had fewer infections and faster blood cell recovery—although the study was too small to properly evaluate clinical outcomes. And in a small study of nine people with metastatic skin cancer, Repasky and her colleagues found hints that beta blockers might boost the effectiveness of cancer immunotherapy treatments. While studies on beta blockers are promising, it's not clear that these drugs will improve outcomes in all kinds of cancers, such as lung cancer and certain subtypes of breast cancer. Some patients can react badly to taking the medications—particularly those with asthma or heart conditions such as bradycardia, in which the heart beats unusually slowly. And, crucially, the drugs only block the endpoint of stress, not its cause, Repasky says. They will therefore likely need to be combined with mindfulness, counseling and other stress-reducing strategies that get closer to the root of the problem. Such interventions are also in the works. Bower and her team have conducted clinical trials of mind-body interventions such as yoga and mindfulness meditation with breast cancer survivors, to improve health and promote lasting remission. They've found that these therapies can decrease inflammatory activity in circulating immune cells, and they speculate that this may help to reduce tumor recurrence. Ultimately, bigger clinical trials are needed to firmly establish the benefits of beta blockers and other stress-reducing interventions on cancer survival outcomes—and determine how long such effects might last. The timing of treatment and the type of cancer being treated may play a role in how well such therapies work, researchers say. But lack of funding has been a barrier to conducting the larger follow-up studies needed to answer such questions. The work isn't yet backed by pharmaceutical companies or other organizations that support large studies in oncology, Knight says. And for now, whether stress can increase a person's risk of developing cancer in the first place, as the ancient Greeks once postulated, remains a mystery. Population studies linking stress to cancer risk are often complicated by other factors, such as smoking, poor nutrition and limited access to health care. "We have no definitive way of saying, 'If you're stressed out, you're going to develop cancer,'" says Patricia Moreno, a clinical psychologist at the University of Miami Miller School of Medicine and coauthor of an article in the 2023 Annual Review of Psychology about stress management interventions in cancer. But for people who already have a cancer diagnosis, many researchers argue that the evidence is strong enough to include stress management in clinical practice. On average, cancer patients do not receive psychological therapies that can reduce stress at the level for which they are needed, says Barbara Andersen, a clinical psychologist at Ohio State University. Although they won't be necessary for every patient, many can benefit from mind-body interventions, she says. "I'm not saying they should be a first priority, but they shouldn't be the last." This story was produced by Knowable Magazine and reviewed and distributed by Stacker.
CBS News
3 days ago
- CBS News
Underwater military drone accidentally stumbles upon deepest shipwreck ever found off France: "As if time froze"
What technology could change the way we learn about shipwrecks What technology could change the way we learn about shipwrecks What technology could change the way we learn about shipwrecks Archaeologists have discovered by chance what they say are the remains of a 16th-century merchant ship more than 1.5 miles underwater off southern France, the deepest such find in its section of the Mediterranean or any other French waters. Archaeologists believe the ship was sailing from northern Italy loaded with ceramics and metal bars before it sunk. Despite a little modern waste dotting its sunken cargo at 8,422 feet below sea level, researchers were excited about the potential of an archaeological site largely preserved intact. "It's the deepest shipwreck ever found in French territorial waters," Arnaud Schaumasse, the head of the culture ministry's underwater archaeology department, said late Wednesday. France's Department of Underwater and Submarine Archaeological Research released images of the shipwreck on social media, saying the vessel was discovered "during a military operation to explore the seabed." Archaeologists say they discovered by chance what they say are the remains of a 16th-century merchant ship more than 1.5 miles underwater off southern France. National Navy via France's Department of Underwater and Submarine Archaeological Research An underwater drone stumbled upon the sunken ship by chance in early March in waters near Saint-Tropez in southeastern France, deputy maritime prefect Thierry de la Burgade said. "The sonar detected something quite big, so we went back with the device's camera, then against with an underwater robot to snap high-quality images," he said. The drone was patrolling the seabed as part of a government project to explore and monitor France's deep-sea resources, from minerals to deep-sea internet cables. Archaeologist Marine Sadania said experts discovered 200 jugs with pinched spouts among the wreckage at the site they have dubbed "Camarat 4." Some of these jugs were marked with the monogram "HIS," the first three letters of the Greek name of Jesus, or covered with plant-inspired or geometric patterns. Those details seemed to indicate the jugs hailed from the Liguria region in what is now northern Italy, she said. "Camarat 4 is a remarkable discovery for its depth, unprecedented character and the opportunity it offers to study an almost intact 16th-century wreck," France's Department of Underwater and Submarine Archaeological Research said. "As if time froze" Experts also identified piles of around 100 yellow plates, two cauldrons, an anchor and six cannons. Modern waste, such as a soda can or an empty yogurt container, were spotted too. One image released by officials appeared to show an aluminum can next to an anchor. Archaeologists say they discovered by chance what they say are the remains of a 16th-century merchant ship more than 1.5 miles underwater off southern France. National Navy via France's Department of Underwater and Submarine Archaeological Research But despite this, "the site -- thanks to its depth which prevented any recovery or looting -- has remained intact, as if time froze, which is exceptional," Sadania said. Over the coming two years, she and colleagues plan to draw up a 3D digital version of the ship, as well as extract samples from the site to better study them before returning them to the public domain. According to the defense ministry in charge of exploring France's deep seas, researchers can remove an item from a shipwreck by guiding a submarine robot with pincers or arms, via a long cable linking the device to a boat on the surface. Officials said further analysis will be carried out by ceramic experts, archaeologists and specialists in naval architecture. The deepest French authorities had found a sunken vessel until now was 2.3 kilometers under sea level off the southern city of Toulon in 2019. The wreckage belonged to La Minerve, a French submarine that plunged to its demise in 1968 with 52 navy crew on board, only four minutes after the start of a routine assignment.
